• eTheRNA
  • Follow our progress in developing products that have the potential to transform the future of cancer treatment

eTheRNA immunotherapies CEO to present at Bio Europe 2017

Niel (Belgium), 1 November 2017 — eTheRNA Immunotherapies, a clinical-stage company developing mRNA-based cancer immunotherapies based on its unique TriMix platform, announces that CEO Dirk Reyn is to present at Bio-Europe 2017 in Berlin.

The presentation will take place on Wednesday 8th November at 9:45am in the ‘Cell and gene therapy track’.

This year’s BIO-Europe conference will take place from 6-8 November at CityCube in Berlin, Germany. The conference brings together thousands of attendees from the life sciences industry and offers the greatest opportunity to meet senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies.